Temperature-regulated Insulin Case Patent

Description:
The Company is a research and development firm that was granted a US patent in 2021, for its bifurcated temperature regulation system, known as the medicament temperature regulator. The modular, heating and cooling system can be applied to various applications, from consumer products to industrial transport, though the intellectual property (IP) was initially developed for the medical industry to regulate the temperature of insulin for those who suffer with diabetes.

Key Aspects:
• Entirely modular and scalable IP, allowing it to be utilized across various industries for a variety of products and solutions
• Fully functioning prototype of the bifurcated temperature regulation system has been developed in-house
• Most technologically advanced insulin case on the market, according to management
• Additional concepts for future product development operates under the guidelines of the original patent and is also included in the sale
• Product is suitable for all climates and can be used for various products, such as insulin pens, syringes, vials, vaccines, and other temperature-sensitive medicaments

Opportunities:
• Capitalize on the US patent the IP currently holds to develop and bring the final product to market to serve the more than 537 million people diagnosed with diabetes worldwide
• Focus on the current capabilities the IP current has for additional products outside of the medical field to expand future product development ideas
• Implement a strategic plan to develop additional revenue streams outside of the product itself, such as battery replacements, chargers, ports, & cords, or other related accessories

Headquartered:
• United States

Potential Markets:
• While the product was initially designed for the medical industry to safely transport temperature-sensitive drugs and medications, such as insulin, the patent is capable of covering a broad range of products for climate control and temperature regulation across various industries
• The product could also be utilized in the medical field for organs, intravenous fluids, and other sensitive medical material transportation
• Outside of the medical field, the patent could be used for products within the food & drug industry, pharmaceutical production, and transportation industry

Shareholder Ownership:
• The Company is solely owned by one shareholder who is looking to either sell or license the patent for the bifurcated temperature regulation system
• The owner notes that the Company has currently taken the product as far as it can go without the need for large capital expenditure to bring the product to market
• The owner has noted that the Company's core goals are to help others bring products to life, with the end goal being for other to bring the final product to market